About Oxford BioTherapeutics
Redefining the cancer-immune synapse for novel immune checkpoint mechanisms
- Industry
- Biotechnology
- Company size
- 11-50 employees
- Headquarters
- Oxford
- Founded
- 2004
- Company type
- Privately Held
Oxford BioTherapeutics (OBT) is a clinical stage oncology company based in Oxford, UK; San Jose, CA and Morristown, NJ, USA, with a pipeline of first-in-class immuno-oncology (IO) and antibody-drug conjugate (ADC) based therapies designed to fulfil major unmet patient needs in cancer therapeutics.
Our lead asset, OBT076, is an Antibody Drug Conjugate (ADC) in Phase 1b clinical development. OBT076's dual mechanism of action allows it to act as a 'primer' to re-engage the patient's immune system while at the same time targeting cancer cells directly.
OBT’s proprietary OGAP® target discovery platform is based on one of the world’s largest proprietary cancer membrane proteomic databases, with data on over 5,000 cancer cell proteins providing unique, highly qualified oncology targets, of which three programs are in clinical development in the USA and Europe.
The company’s pipeline and development capabilities have been validated through multiple strategic partnerships, including with Boehringer Ingelheim, ImmunoGen and Kite Pharma as well as other world leaders in antibody development (such as Amgen, WuXi, Medarex (BMS), Alere (Abbott)).
Specialties
- Cancer
- Biotechnology
- Oncology
- Proteomics
- Protein Target Discovery
- Antibody-Drug Conjugates
- and Immune-Oncology
Company locations
The Schrodinger Building, Oxford Science Park, Suite A, Second Floor, Oxford, OX4 4GE, GB
San Jose Biocenter, 5941 Optical Court, San Jose, California 95138, US
Morristown, New Jersey, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
Business areas
- Health Diagnostics
- Health Care
- Biotechnology
- Genetics
- Therapeutics
On LinkedIn
- Followers
- 10,978
- People linked to this company
- 64
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Funding raised
33,217,286 USD
Total reported by Crunchbase, in US dollars. This is funding raised, not company revenue or valuation.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.